Intravenous anesthesia for the patient with left ventricular dysfunction (Q36480106)

14 August 2017

1 reference

title

Intravenous anesthesia for the patient with left ventricular dysfunction (English)

1 reference

14 August 2017

1 reference

ventricular dysfunction

1 reference

J G Bovill

1

1 reference

PubMed ID

16703233

14 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

Seminars in Cardiothoracic and Vascular Anesthesia

14 August 2017

1 reference

14 August 2017

10

1 reference

14 August 2017

1

1 reference

14 August 2017

43-48

1 reference

Inotropic effects of propofol, thiopental, midazolam, etomidate, and ketamine on isolated human atrial muscle.

14 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Influence of thiopental, etomidate, and propofol on regional myocardial function in the normal and acute ischemic heart segment in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Effects of ketamine on the contractility of failing and nonfailing human heart muscles in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

The inotropic and lusitropic effects of ketamine in isolated human atrial myocardium: the effect of adrenoceptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Actions of ketamine and its isomers on contractility and calcium transients in human myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Ketamine preconditions isolated human right atrial myocardium: roles of adenosine triphosphate-sensitive potassium channels and adrenoceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Off-pump coronary artery bypass surgery: physiology and anaesthetic management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

The contribution of the coronary concentrations of propofol to its cardiovascular effects in anesthetized sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Cardiovascular effects of intravenous propofol administered at two infusion rates: a transthoracic echocardiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Propofol inhibits Ca(2+) transients but not contraction in intact beating guinea pig hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

The effects of propofol on the contractility of failing and nonfailing human heart muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Propofol increases myofilament Ca2+ sensitivity and intracellular pH via activation of Na+-H+ exchange in rat ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Propofol increases contractility during alpha1a-adrenoreceptor activation in adult rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Direct cardiac effects of coronary site-directed thiopental and its enantiomers: a comparison to propofol in conscious sheep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Tissue/blood and tissue/water partition coefficients for propofol in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Myocardial pharmacokinetics of thiopental in sheep after short-term administration: relationship to thiopental-induced reductions in myocardial contractility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Myocardial and coronary effects of propofol in rabbits with compensated cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Myocardial effects of propofol in hamsters with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Negative and selective effects of propofol on isolated swine myocyte contractile function in pacing-induced congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Propofol alters left ventricular afterload as evaluated by aortic input impedance in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Cardiovascular effects of propofol in dogs with dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Conscious sedation with midazolam or propofol does not alter left ventricular diastolic performance in patients with preexisting diastolic dysfunction: a transmitral and tissue Doppler transthoracic echocardiography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Anaesthetics and cardiac preconditioning. Part II. Clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Myocardial injury and its prevention in the perioperative setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F(2t)-isoprostane formation and tissue antioxidant capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Intracoronary propofol attenuates myocardial but not coronary endothelial dysfunction after brief ischaemia and reperfusion in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Cardioprotective effects of propofol and sevoflurane in ischemic and reperfused rat hearts: role of K(ATP) channels and interaction with the sodium-hydrogen exchange inhibitor HOE 642 (cariporide).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Clinically relevant concentrations of propofol have no effect on adenosine triphosphate-sensitive potassium channels in rat ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Molecular mechanisms of the inhibitory effects of propofol and thiamylal on sarcolemmal adenosine triphosphate-sensitive potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Inhibition of lipid peroxidation in isolated rat liver mitochondria by the general anaesthetic propofol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

The antioxidant potential of propofol (2,6-diisopropylphenol).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Propofol attenuates hydrogen peroxide-induced mechanical and metabolic derangements in the isolated rat heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Mitochondrial permeability transition and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Mitochondrial permeability transition pore as a target for cardioprotection in the human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Preconditioning protects by inhibiting the mitochondrial permeability transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

In vitro electrophysiologic effects of morphine in rabbit ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Opioid receptor independent effects of morphine on membrane currents in single cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Electrophysiological effects of morphine in an in vitro model of the 'border zone' between normal and ischaemic-reperfused guinea-pig myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Opioids and cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Opioid preconditioning: myocardial function and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Remifentanil preconditioning protects against ischemic injury in the intact rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Morphine enhances pharmacological preconditioning by isoflurane: role of mitochondrial K(ATP) channels and opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Role of delta-opioid receptor agonists on infarct size reduction in swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Fentanyl protects the heart against ischaemic injury via opioid receptors, adenosine A1 receptors and KATP channel linked mechanisms in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Essential activation of PKC-delta in opioid-initiated cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Fentanyl reduces infarction but not stunning via delta-opioid receptors and protein kinase C in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

Morphine induces late cardioprotection in rat hearts in vivo: the involvement of opioid receptors and nuclear transcription factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F108925320601000108

10.1177/108925320601000108

21 January 2018

Identifiers

DOI

0 references

PubMed ID

16703233

1 reference

PubMed ID

16703233